Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Assessing Needs for Cancer Education and Support in American Indian and Alaska Native Communities in the Northwestern United States.

Harris R, Van Dyke ER, Ton TG, Nass CA, Buchwald D.

Health Promot Pract. 2016 Nov;17(6):891-898. Epub 2015 Oct 26.

PMID:
26507742
2.

Does the mask govern the mind?: effects of arbitrary gender representation on quantitative task performance in avatar-represented virtual groups.

Lee JE, Nass CI, Bailenson JN.

Cyberpsychol Behav Soc Netw. 2014 Apr;17(4):248-54. doi: 10.1089/cyber.2013.0358. Epub 2014 Jan 30.

PMID:
24479529
3.

Using music to change mood while driving.

van der Zwaag MD, Janssen JH, Nass C, Westerink JH, Chowdhury S, de Waard D.

Ergonomics. 2013;56(10):1504-14. doi: 10.1080/00140139.2013.825013. Epub 2013 Sep 2.

PMID:
23998711
4.

Ethanol- and/or Taurine-Induced Oxidative Stress in Chick Embryos.

Berning EJ, Bernhardson N, Coleman K, Farhat DA, Gushrowski CM, Lanctot A, Maddock BH, Michels KG, Mugge LA, Nass CM, Yearsley SM, Miller RR Jr.

J Amino Acids. 2013;2013:240537. doi: 10.1155/2013/240537. Epub 2013 Mar 21.

5.

[Single-port access cholecystectomy is a safe alternative to conventional laparoscopic cholecystectomy: a retrospective comparison of single-port access versus standard laparoscopic cholecystectomy].

Cziupka K, Partecke LI, Nass C, Mirow L.

Zentralbl Chir. 2013 Feb;138(1):70-5. doi: 10.1055/s-0031-1283886. Epub 2012 Mar 16. German.

PMID:
22426970
6.

Media use, face-to-face communication, media multitasking, and social well-being among 8- to 12-year-old girls.

Pea R, Nass C, Meheula L, Rance M, Kumar A, Bamford H, Nass M, Simha A, Stillerman B, Yang S, Zhou M.

Dev Psychol. 2012 Mar;48(2):327-36. doi: 10.1037/a0027030. Epub 2012 Jan 23.

PMID:
22268607
7.

The Native Comic Book Project: native youth making comics and healthy decisions.

Montgomery M, Manuelito B, Nass C, Chock T, Buchwald D.

J Cancer Educ. 2012 Apr;27(1 Suppl):S41-6. doi: 10.1007/s13187-012-0311-x.

8.

Cognitive control in media multitaskers.

Ophir E, Nass C, Wagner AD.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15583-7. doi: 10.1073/pnas.0903620106. Epub 2009 Aug 24.

9.

Assessing the effectiveness of interactive media in improving drowsy driver safety.

Takayama L, Nass C.

Hum Factors. 2008 Oct;50(5):772-81.

PMID:
19110837
10.
11.

role of altruistic behavior, empathetic concern, and social responsibility motivation in blood donation behavior.

Steele WR, Schreiber GB, Guiltinan A, Nass C, Glynn SA, Wright DJ, Kessler D, Schlumpf KS, Tu Y, Smith JW, Garratty G; Retrovirus Epidemiology Donor Study.

Transfusion. 2008 Jan;48(1):43-54. Epub 2007 Sep 24.

PMID:
17894795
12.

Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.

Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL; HTLV Outcomes Study (HOST) Investigators.

J Infect Dis. 2006 Dec 1;194(11):1557-64. Epub 2006 Oct 27.

PMID:
17083040
13.
14.

Convenience, the bane of our existence, and other barriers to donating.

Schreiber GB, Schlumpf KS, Glynn SA, Wright DJ, Tu Y, King MR, Higgins MJ, Kessler D, Gilcher R, Nass CC, Guiltinan AM; National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study.

Transfusion. 2006 Apr;46(4):545-53.

PMID:
16584430
15.

Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication.

Gabet AS, Moulés V, Sibon D, Nass CC, Mortreux F, Mauclère P, Gessain A, Murphy EL, Wattel E.

Virology. 2006 Feb 5;345(1):13-21. Epub 2005 Oct 26.

16.

Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction.

Martinez EA, Nass CM, Jermyn RM, Rosenbaum SH, Akhtar S, Chan DW, Malkus H, Weiss JL, Fleisher LA.

J Cardiothorac Vasc Anesth. 2005 Oct;19(5):577-82.

PMID:
16202889
17.

The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.

Kleinman SH, Glynn SA, Higgins MJ, Triulzi DJ, Smith JW, Nass CC, Garratty G, Murphy EL, LeParc GF, Schreiber GB, King MR, Chamberland ME, Nemo GJ.

Transfusion. 2005 Jul;45(7):1073-83.

PMID:
15987350
18.
19.

Inspired oxygen fraction of 0.8 does not attenuate postoperative nausea and vomiting after strabismus surgery.

Treschan TA, Zimmer C, Nass C, Stegen B, Esser J, Peters J.

Anesthesiology. 2005 Jul;103(1):6-10.

PMID:
15983450
20.

A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II.

Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL; HTLV Outcomes Study Investigators.

J Infect Dis. 2005 May 1;191(9):1490-7. Epub 2005 Mar 31.

PMID:
15809908
21.

The impact of male-to-male sexual experience on risk profiles of blood donors.

Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2005 Mar;45(3):404-13.

PMID:
15752159
22.

Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.

Wang B, Higgins MJ, Kleinman S, Schreiber GB, Murphy EL, Glynn SA, Wright DJ, Nass CC, Chang D, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2004 Aug;44(8):1243-51.

PMID:
15265131
23.

Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D; HTLV Outcomes Study Investigators.

J Infect Dis. 2004 Aug 1;190(3):504-10. Epub 2004 Jul 6.

PMID:
15243924
24.

Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study.

Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL; HOST Investigators.

Retrovirology. 2004 Mar 24;1:4.

25.

Mammalian brain consumption by blood donors in the United States: brains today, deferred tomorrow?

Schreiber GB, Sanchez AM, Garratty G, Nass CC, Tu Y, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2004 May;44(5):667-74.

PMID:
15104646
26.

The donor notification process from the donor's perspective.

Kleinman S, Wang B, Wu Y, Glynn SA, Williams A, Nass C, Ownby H, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2004 May;44(5):658-66.

PMID:
15104645
27.

Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.

Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB.

Emerg Infect Dis. 2004 Jan;10(1):109-16.

28.

Clinical challenges: the intersection of diabetes, chronic kidney disease, and cardiovascular disease.

Nass CM, Reck K.

Curr Diab Rep. 2004 Feb;4(1):1-2. No abstract available.

PMID:
14764271
29.

The value of preoperative pharmacologic stress testing before vascular surgery using ACC/AHA guidelines: a prospective, randomized trial.

Falcone RA, Nass C, Jermyn R, Hale CM, Stierer T, Jones CE, Walters GK, Fleisher LA.

J Cardiothorac Vasc Anesth. 2003 Dec;17(6):694-8.

PMID:
14689407
30.

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, Garratty G, Newman B, Smith D, Wang B, Loughlin K, Murphy EL; HTLV Outcomes Study.

Neurology. 2003 Dec 9;61(11):1588-94.

PMID:
14663047
31.

Do blood donors read and understand screening educational materials?

Rugege-Hakiza SE, Glynn SA, Hutching ST, Bethel J, Nass CC, McEntire RL, Hirschler NV, Campbell JG, Ladavac A, Schreiber GB; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Aug;43(8):1075-83.

PMID:
12869113
32.

Anti-atherosclerotic effects of statins: lessons from prevention trials.

Ganesh SK, Nass CM, Blumenthal RS.

J Cardiovasc Risk. 2003 Jun;10(3):155-9. Review.

PMID:
12775947
33.

Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site.

Wang B, Schreiber GB, Glynn SA, Nass CC, Smith JW, Higgins MJ, Hutching ST, Wright DJ, McEntire RL, Murphy EL; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Jun;43(6):705-12.

PMID:
12757520
34.

Attitudes toward blood donation incentives in the United States: implications for donor recruitment.

Glynn SA, Williams AE, Nass CC, Bethel J, Kessler D, Scott EP, Fridey J, Kleinman SH, Schreiber GB; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Jan;43(1):7-16.

PMID:
12519425
35.

Percutaneous coronary intervention vs. medical therapy: what are the implications for women?

Haymart MR, Dickfeld T, Nass C, Blumenthal RS.

J Womens Health Gend Based Med. 2002 May;11(4):347-55. Review.

PMID:
12150497
36.

Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy.

Cheng A, Braunstein JB, Dennison C, Nass C, Blumenthal RS.

Clin Cardiol. 2002 May;25(5):205-12. Review.

37.

Knowledge of HIV/AIDS transmission and screening in United States blood donors.

Sharma UK, Schreiber GB, Glynn SA, Nass CC, Higgins MJ, Tu Y, Bethel J, Williams AE; Retrovirus Epidemiology Donor Study.

Transfusion. 2001 Nov;41(11):1341-50.

PMID:
11724976
39.

Lipid disorders: justification of methods and goals of treatment.

Braunstein JB, Cheng A, Cohn G, Aggarwal M, Nass CM, Blumenthal RS.

Chest. 2001 Sep;120(3):979-88. Review.

PMID:
11555537
40.

Repeat whole-blood and plateletpheresis donors:unreported deferrable risks, reactive screening tests, andresponse to incentive programs.

Glynn SA, Smith JW, Schreiber GB, Kleinman SH, Nass CC, Bethel J, Biswas B, Thomson RA, Williams AE; Retrovirus Epidemiology Donor Study.

Transfusion. 2001 Jun;41(6):736-43.

PMID:
11399812
41.
42.

ABCs of cardiovascular disease risk management.

Braunstein JB, Cheng A, Fakhry C, Nass CM, Vigilance C, Blumenthal RS.

Cardiol Rev. 2001 Mar-Apr;9(2):96-105. Review.

PMID:
11209148
43.

Glitazones and the potential improvement of lipid profiles in diabetes patients at high risk for cardiovascular disease.

Nass CM, Blumenthal RS.

Am J Manag Care. 2000 Dec;6(24 Suppl):S1247-56; quiz S1257-8.

44.

Effectiveness of remifentanil versus traditional fentanyl-based anesthetic in high-risk outpatient surgery.

Mackey JJ, Parker SD, Nass CM, Snyder DS, Curreri S, Kazim D, Zuckerman RL, Fleisher LA.

J Clin Anesth. 2000 Sep;12(6):427-32.

PMID:
11090727
45.

Global risk assessment for lipid therapy to prevent coronary heart disease.

Nass CM, Wiviott SD, Allen JK, Post WS, Blumenthal aR.

Curr Cardiol Rep. 2000 Sep;2(5):424-32.

PMID:
10980910
46.

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE.

JAMA. 2000 Jul 12;284(2):229-35.

PMID:
10889598
47.

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ.

Hepatology. 2000 Mar;31(3):756-62.

PMID:
10706569
48.

Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.

Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G.

J Infect Dis. 1999 Dec;180(6):1777-83.

PMID:
10558931
49.

Analysis of donor return behavior. Retrovirus Epidemiology Donor Study.

Ownby HE, Kong F, Watanabe K, Tu Y, Nass CC.

Transfusion. 1999 Oct;39(10):1128-35.

PMID:
10532608
50.

Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.

Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC, Ownby HE, Wright DJ, Nemo GJ.

Arch Intern Med. 1999 Jul 12;159(13):1485-91.

PMID:
10399901

Supplemental Content

Support Center